WuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product Candidates
Published on 08/07/2025 at 18:06 | prnewswire.co.uk
en | CA7609751028 | WUXI | boerse | 67950578 |
